髓系细胞触发受体-1在肝脏及相关炎症性疾病中的研究进展

摘要/Abstract

摘要： 髓系细胞触发受体-1(triggering receptor expressed on myeloid cells-1, TREM-1)主要包括结构完整的膜受体TREM-1及缺乏跨膜结构域的可溶性TREM-1(soluble triggering receptor expressed on myeloid cells-1,sTREM-1)两种形式。近年来结构完整的膜受体TREM-1在多种肝脏及炎症性疾病中已有相关研究,而作为一种与炎症反应密切相关的细胞因子sTREM-1在肝脏疾病中的研究仍然较少。现就这两种不同形式的TREM-1在肝脏及其相关炎症性疾病中的研究所取得的进展作一综述。

关键词: 髓系细胞触发受体-1, 可溶性髓系细胞触发受体-1, 肝脏疾病, 炎症

陈淑佳, 祁胜宾. 髓系细胞触发受体-1在肝脏及相关炎症性疾病中的研究进展[J]. 肝脏, 2023, 28(7): 849-852.

参考文献

[1] Peng L, Zhou Y, Dong L, et al. Tgf-beta1 upregulates the expression of triggering receptor expressed on myeloid cells 1 in murine lungs. Sci Rep, 2016, 6:18946.
[2] Prufer S, Weber M, Sasca D, et al. Distinct signaling cascades of trem-1, tlr and nlr in neutrophils and monocytic cells. J Innate Immun, 2014, 6(3):339-352.
[3] Klesney-Tait J, Turnbull IR, Colonna M. The trem receptor family and signal integration. Nat Immunol, 2006, 7(12):1266-1273.
[4] Parola M, Pinzani M. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med, 2019, 65:37-55.
[5] Rao S, Huang J, Shen Z, et al. Inhibition of trem-1 attenuates inflammation and lipid accumulation in diet-induced nonalcoholic fatty liver disease. J Cell Biochem, 2019, 120(7):11867-11877.
[6] Yao Q, Li S, Li X, et al. Myricetin modulates macrophage polarization and mitigates liver inflammation and fibrosis in a murine model of nonalcoholic steatohepatitis. Front Med (Lausanne), 2020, 7:71.
[7] Dou ZF, Guo YR, Liu JC, et al. Ameliorative effects of glycine in an experimental nonalcoholic steatohepatitis and its correlation between trem-1 and trem-2. Am J Transl Res, 2016, 8(2):284-297.
[8] Tornai D, Furi I, Shen ZT, et al. Inhibition of triggering receptor expressed on myeloid cells 1 ameliorates inflammation and macrophage and neutrophil activation in alcoholic liver disease in mice. Hepatol Commun, 2019, 3(1):99-115.
[9] Xiang DM, Sun W, Ning BF, et al. The hlf/il-6/stat3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. Gut, 2018, 67(9):1704-1715.
[10] Pradere JP, Kluwe J, De Minicis S, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology, 2013, 58(4):1461-1473.
[11] Nguyen-Lefebvre AT, Ajith A, Portik-Dobos V, et al. The innate immune receptor trem-1 promotes liver injury and fibrosis. J Clin Invest, 2018, 128(11):4870-4883.
[12] Nochi H, Aoki N, Oikawa K, et al. Modulation of hepatic granulomatous responses by transgene expression of dap12 or trem-1-ig molecules. Am J Pathol, 2003, 162(4):1191-1201.
[13] Bai F, Huang Q, Nie J, et al. Trolline ameliorates liver fibrosis by inhibiting the nf-κb pathway, promoting hsc apoptosis and suppressing autophagy. Cell Physiol Biochem, 2017, 44(2):436-446.
[14] Kiagiadaki F, Kampa M, Voumvouraki A, et al. Activin-a causes hepatic stellate cell activation via the induction of tnfα and tgfβ in kupffer cells. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(3):891-899.
[15] Fabregat I, Caballero-Díaz D. Transforming growth factor-β-induced cell plasticity in liver fibrosis and hepatocarcinogenesis. Front Oncol, 2018, 8:357.
[16] Liao R, Sun TW, Yi Y, et al. Expression of trem-1 in hepatic stellate cells and prognostic value in hepatitis b-related hepatocellular carcinoma. Cancer Sci, 2012, 103(6):984-992.
[17] Wu Q, Zhou W, Yin S, et al. Blocking triggering receptor expressed on myeloid cells-1-positive tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-programmed cell death ligand 1 resistance in liver cancer. Hepatology, 2019, 70(1):198-214.
[18] Jung KH, Yoo W, Stevenson HL, et al. Multifunctional effects of a small-molecule stat3 inhibitor on nash and hepatocellular carcinoma in mice. Clin Cancer Res, 2017, 23(18):5537-5546.
[19] Wu J, Li J, Salcedo R, et al. The proinflammatory myeloid cell receptor trem-1 controls kupffer cell activation and development of hepatocellular carcinoma. Cancer Res, 2012, 72(16):3977-3986.
[20] He Y, Yang Q, Wang X, et al. Inhibition of triggering receptor expressed on myeloid cell-1 alleviates acute gouty inflammation. Mediators Inflamm, 2019, 2019:5647074.
[21] Zhu H, Li W, Wang Z, et al. Trem-1 deficiency attenuates the inflammatory responses in lps-induced murine endometritis. Microb Biotechnol, 2019, 12(6):1337-1345.
[22] Feng CW, Chen NF, Sung CS, et al. Therapeutic effect of modulating trem-1 via anti-inflammation and autophagy in parkinson's disease. Front Neurosci, 2019, 13:769.
[23] Yin K, Dang SC, Zhang JX. Relationship between expression of triggering receptor-1 on myeloid cells in intestinal tissue and intestinal barrier dysfunction in severe acute pancreatitis. World J Emerg Med, 2011, 2(3):216-221.
[24] Wang Y, Xie X, Liu H, et al. Lr12 promotes liver repair by improving the resolution of inflammation and liver regeneration in mice with thioacetamide- (taa-) induced acute liver failure. Mediators Inflamm, 2021, 2021:2327721.
[25] Borjas T, Jacob A, Yen H, et al. Inhibition of the interaction of trem-1 and ecirp attenuates inflammation and improves survival in hepatic ischemia/reperfusion. Shock, 2022, 57(2):246-255.
[26] Wu X, Cai B, Lu W, et al. Hbv upregulated triggering receptor expressed on myeloid cells-1 (trem-1) expression on monocytes participated in disease progression through nf-kb pathway. Clin Immunol, 2021, 223:108650.
[27] Li X, Yao Q, Huang J, et al. Morin hydrate inhibits trem-1/tlr4-mediated inflammatory response in macrophages and protects against carbon tetrachloride-induced acute liver injury in mice. Front Pharmacol, 2019, 10:1089.
[28] Chen LC, Laskin JD, Gordon MK, et al. Regulation of trem expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp Mol Pathol, 2008, 84(2):145-155.
[29] Hyun J, McMahon RS, Lang AL, et al. Hiv and hcv augments inflammatory responses through increased trem-1 expression and signaling in kupffer and myeloid cells. PLoS Pathog, 2019, 15(7):e1007883.
[30] Chin VK, Asyran AMY, Zakaria ZA, et al. Trem-1 modulation produces positive outcome on the histopathology and cytokines release profile of plasmodium berghei-infected mice. J Parasit Dis, 2019, 43(1):139-153.
[31] Maiese A, Bolino G, Mastracchio A, et al. An immunohistochemical study of the diagnostic value of trem-1 as marker for fatal sepsis cases. Biotech Histochem, 2019, 94(3):159-166.
[32] Subramanian S, Pallati PK, Sharma P, et al. Trem-1 associated macrophage polarization plays a significant role in inducing insulin resistance in obese population. J Transl Med, 2017, 15(1):85.
[33] Lin YT, Tseng KY, Yeh YC, et al. Trem-1 promotes survival during klebsiella pneumoniae liver abscess in mice. Infect Immun, 2014, 82(3):1335-1342.
[34] Zhang J, She D, Feng D, et al. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (strem-1) reflect sepsis severity and can predict prognosis: A prospective study. BMC Infect Dis, 2011, 11:53.
[35] Liu XR, Xu J, Wang YM, et al. The effects of paeoniflorin injection on soluble triggering receptor expressed on myeloid-1 (strem-1) levels in severe septic rats. Korean J Physiol Pharmacol, 2016, 20(6):565-571.
[36] Choi ST, Kang EJ, Ha YJ, et al. Levels of plasma-soluble triggering receptor expressed on myeloid cells-1 (strem-1) are correlated with disease activity in rheumatoid arthritis. J Rheumatol, 2012, 39(5):933-938.
[37] Yasuda T, Takeyama Y, Ueda T, et al. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Crit Care Med, 2008, 36(7):2048-2053.
[38] Zaki MES, Abed S, Elegezy M, et al. Can triggering receptors on myeloid cells be used for diagnosis of salmonella typhi infection? Endocr Metab Immune Disord Drug Targets, 2020, 20(9):1488-1493.
[39] Edel Y, Kliminski V, Pokroy-Shapira E, et al. Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome. Arthritis Res Ther, 2019, 21(1):10.
[40] Patoulias D, Kalogirou MS, Patoulias I. Triggering receptor expressed on myeloid cells-1 (trem-1) and its soluble in the plasma form (strem-1) as a diagnostic biomarker in neonatal sepsis. Folia Med Cracov, 2018, 58(2):15-19.
[41] Kamei K, Yasuda T, Ueda T, et al. Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. J Hepatobiliary Pancreat Sci, 2010, 17(3):305-312.
[42] Baruah S, Keck K, Vrenios M, et al. Identification of a novel splice variant isoform of trem-1 in human neutrophil granules. J Immunol, 2015, 195(12):5725-5731.
[43] Liu T, Chen S, Xie X, et al. Soluble trem-1, as a new ligand for the membrane receptor robo2, promotes hepatic stellate cells activation and liver fibrosis. J Cell Mol Med, 2021, 25(24):11113-11127.